Search results
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 9 hours agoPrevnar sales inched 2% ahead to $6.44 billion. But other key products saw downfalls. Revenue from...
Are your prescription drugs affordable? Colorado board wants feedback on these 2
KDVR Denver via Yahoo News· 1 day agoThe body was created in 2021 to review prescription drugs and evaluate their affordability for...
Remicade and interactions: Other drugs, alcohol, and more
Medical News Today· 7 days agoBefore you start treatment with Remicade, tell your doctor and pharmacist which prescription,...
Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever
Motley Fool via Yahoo Finance· 2 days agoIt aims to develop or acquire lower-risk, less splashy drugs it knows it can market. Underscoring...
Meet The Billionaire-Owned Company Making Injectors For Blockbuster Drugs Like Ozempic
Forbes· 7 days agoThe runaway success of weight loss drugs took the markets by storm last year, spurring huge stock gains for drugmakers like Novo Nordisk, which makes Wegovy and Ozempic. Most patients take them ...
Indemnity Ins. Co. of N. Am. v. Unitrans Int'l Corp. | New York Law Journal
Law.com· 7 days agoIndemnity Insurance Company of North America (“Indemnity”) appeals from the district court’s grant of summary judgment in favor of Unitrans International Corporation (“Unitrans”) on Indemnity ...
Looking At Amgen's Recent Unusual Options Activity - Amgen (NASDAQ:AMGN)
Benzinga· 6 days agoFlagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced ...
William Blair Comments on Amgen Inc.’s Q1 2024 Earnings (NASDAQ:AMGN)
ETF DAILY NEWS· 18 hours agoAmgen Inc. (NASDAQ:AMGN – Free Report) – Equities researchers at William Blair reduced their Q1 2024 earnings per share (EPS) estimates for Amgen in a research note issued on Wednesday, April ...
Q1 2024 EPS Estimates for Biogen Inc. (NASDAQ:BIIB) Lifted by Analyst
ETF DAILY NEWS· 7 days agoBiogen Inc. (NASDAQ:BIIB – Free Report) – Stock analysts at Leerink Partnrs boosted their Q1 2024 EPS estimates for shares of Biogen in a note issued to investors on Tuesday, April 9th. Leerink ...
Biogen Inc. (NASDAQ:BIIB) Short Interest Update
ETF DAILY NEWS· 4 days agoBiogen Inc. (NASDAQ:BIIB – Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 3,550,000 ...
